Background-Integrins play an important role for vascular smooth muscle cell (VSMC) migration during the development of atherosclerosis and restenosis. Integrin ␣ v -subunit consists of disulphide-bound 125-kDa heavy and 25-kDa light chains, which are generated by endoproteolytic cleavage. This type of activation requires the presence of suitable proprotein convertases (PCs). Based on ex vivo and in vitro data, the PC5 isozyme has been suggested to be the major integrin convertase. We have recently demonstrated that PC5 is upregulated during vascular remodeling in rodents, colocalizing with ␣ v in VSMCs. The aim of this study was to investigate the activation of ␣ v by PCs in VSMCs and its consequences for ␣ v -dependent cell functions. Methods and Results-Immunoblotting demonstrated that inhibition of PC activity by the specific pharmacological inhibitor dec-CMK inhibits ␣ v cleavage in VSMCs. These results were confirmed using PC5-specific antisense oligonucleotides. PC5-antisense oligonucleotides and dec-CMK inhibited VSMC adhesion to the ␣ v ␤ 3 /␤ 5 ligand vitronectin (both PϽ0.05). Furthermore, PC5-asODNs inhibited VSMC migration on vitronectin-coated wells (PϽ0.05). Inhibition of PC activity and consequently ␣ v cleavage inhibited the adhesion-dependent focal adhesion kinase Y397 -autophosphorylation and subsequent Akt activation, whereas phosphorylation of extracellular signalregulated kinase 1/2 was not affected. In human endarterectomy lesions, PC5 colocalized with ␣ v integrin in VSMCs in the atherosclerotic plaques. Conclusions-The present study demonstrates that ␣ v endoproteolytic activation is necessary for integrin-mediated adhesion and migration as well as signaling and requires PC5 in VSMCs. The colocalization of PC5 and ␣ v in human carotid plaques indicates that PC5 might play a key role for ␣ v activation in vivo. (Circulation. 2004;109:770-776.) 
P roliferation and migration of vascular smooth muscle cells (VSMCs) are key elements in atherosclerosis and restenosis. 1 Both require integrins, which link the extracellular matrix (ECM) with the cytoskeleton, mediating mechanotransduction 2 and bidirectional signaling. 3 Activation of nonreceptor protein tyrosine kinases, such as focal adhesion kinase (FAK), 4 are involved in transducing integrin signaling, which lack intrinsic tyrosine kinase activity themselves. 3 Engagement of integrins involves activation of additional downstream signaling pathways, such as Ras/MEK and PI3-kinase/Akt, 3 as well as conformational changes 5 and integrin/growth factor receptor clustering at focal adhesion sites. 6 The integrins ␣ v ␤ 3 and ␣ v ␤ 5 are upregulated in the neointima after vascular injury 7, 8 and are expressed in VSMCs in atherosclerotic lesions. 9, 10 Both integrins are required for VSMC adhesion and migration to vitronectin 7, 8 and osteopontin 11 in vitro. Targeting ␣ v integrins has been demonstrated to prevent neointima formation, 7, 8, 12 emphasizing their critical role in atherosclerosis and restenosis.
Like other arginine-glycine-aspartate (RGD)-recognizing ␣-integrins, 5 the ␣ v subunit consists of disulfide-bound chains of 125 and 25 kDa, which are generated by endoproteolytic cleavage. 13 Cleavage of ␣-subunits can regulate integrin functions 14, 15 and requires the presence of suitable subtilisin/ kexin-like proprotein convertases (PCs). These enzymes are responsible for the activation of a variety of precursor proproteins to become biologically active. 16 Based on experiments involving the overexpression of individual PCs (including PC1, PC2, PACE4, furin, PC5, and PC7) and ␣ v , PC5 has been suggested to be the major ␣ v convertase. 17 We have recently reported the upregulation of PC5 in PDGF-BBstimulated proliferating VSMCs, whereas furin was unaffected by this growth factor. 18 Furthermore, PC5 and ␣ v are coordinately upregulated and colocalize in neointima VSMCs after balloon injury in rodents, 19 supporting the concept that PC5 may play a functional role for ␣ v activation in VSMCs.
In addition to PC-dependent cleavage, an alternative pathway for ␣ v cleavage involving the membrane-bound matrix metalloproteinase MT1-MMP has been reported recently. 20 Thus, the present study was done to identify the ␣ v processing enzyme and to investigate the function of ␣ v endoproteolytic cleavage in VSMCs.
Methods

Materials
Cell culture media and materials were from GIBCO. Rat vitronectin and type I collagen were from Sigma. The broad-spectrum hydroxamate class MMP-inhibitor GM6001 (Ilomastat) was purchased from Chemicon, and the furin-like PC-inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone (dec-CMK) was from Bachem. Phosphorothioate-conjugated antisense oligodesoxynucleotiodes (asODNs) were costume made and purified (Ͼ98%) by HPLC (TIB-MOLBIOL). All other chemicals were from Sigma. The following antibodies were used: ␣-smooth muscle actin (␣-SMA; Dako), rabbit antibodies to PC5 and furin (both IRCM), ␣ v N-terminal sequence (VNR139; Calbiochem), and ␣ v C-terminal sequence (AB1930; Chemicon). The MT1-MMP antibody (CL1MMP14) was from Cedarlane, and CD68 was from Dako. Induction of signaling pathways was detected with phospho-specific antibodies, recognizing FAK when phosphorylated at tyrosine 397 (Upstate), ERK1/2 MAP-kinase when phosphorylated at threonine 183, and tyrosine 185 (Promega) and Akt when phosphorylated at serin 473 (Cell Signaling). Membranes were reblotted with antibodies to total FAK, Akt, and ERK1/2, purchased from Santa Cruz (FAK) and Cell Signaling (Akt; ERK1/2). The ␣ v ␤ 5 blocking antibody P1F6 was from GIBCO.
Cell Culture
Culture of rat VSMCs was done as described. 18 Subconfluent cells of passages 3 through 6 were used and rendered quiescent by serum starvation (0% FCS) overnight. Pharmacological inhibitor experiments were done in the presence of 2.5% FCS. The ␣ v ␤ 5 blocking antibody (P1F6) was used as described by others. 10, 11 Cell viability was assessed by trypan-blue staining. All experiments were done in triplicate with different preparations of VSMCs.
Liposomal Transfection
AsODNs were used to silence PC5 protein levels. The following PC5-asODNs were used: 5ЈTCCTTACTCCGTCCAC3Ј (PC5-asODN-1), 5ЈGCAACTTGCCAGAGCAT3Ј (PC5-asODN-2), and 5ЈCCAGTCCATGGTCCCGA3Ј (PC5-asODN-3). Specificity of PC5-asODN-2 was additionally assessed with sense (5ЈATGCTCT-GGCAAGTTGC3Ј) and scrambled (5ЈCATGACTACGCTCA-GAG3Ј) ODNs. A 19-mer asODNs targeting ␣ 1 -collagen was used as additional control. 21 Transfection was done with the help of Oligo-fectAMINE (GIBCO), used according to the manufacturer. Briefly, subconfluent VSMCs were growth arrested overnight. Cells were then incubated in OptiMEM (GIBCO) supplemented with ODNs for 6 hours. Then 0.2% FCS was added and cells were maintained for an additional 18 hours. After this, the medium was replaced by 2.5% FCS-DMEM supplemented with ODNs. Successful transfection was determined with an FITC-conjugated PC5-asODN-2 by immunofluorescence.
Western Blots
Immunoblotting was performed as described 18 using 8% or 10% SDS-PAGE with or without reduction with ␤-mercaptoethanol. Semiquantitative densitometry was done using the NIH program 1.62 and is expressed in arbitrary units.
Gelatin Zymography
Supernatants were electrophoresed in 10% SDS-PAGE containing 0.1% gelatin. Briefly, gels were renaturated by exchanging SDS to Triton X-100 (2.5%). Gels were then incubated for 24 to 48 hours at room temperature in activation buffer (50 mmol/L Tris-base, pH 7.6; 5 mmol/L CaCl 2 ; 0.2 mol/L NaCl; and 0.02% Brij) and stained with Coomassie staining solution (0.5% Coomassie R250; 30% MeOH; 10% acetic acid) overnight, followed by destaining (50% MeOH and 10% acetic acid).
BrdU Assay
VSMCs were serum-starved for 48 hours and then transfected with asODNs as described above, followed by stimulation with 5% FCS. BrdU was added after 24-hour stimulation for another 8 hours, and supernatants were then analyzed with a commercially available ELISA (Boehringer).
Adhesion Assay
Microtiter plates (96-wells) were coated with rat vitronectin (10 g/mL) or rat type I collagen (20 g/mL) for 16 hours at 4°C. Plates were then washed with PBS and incubated with PBS containing 1% BSA for 60 minutes at room temperature to block nonspecific binding. VSMCs (30 000/well) were seeded and allowed to adhere for 2 hours at 37°C. After washing, attached cells were fixed with 4% paraformaldehyde (pH 7.5), stained with 0.5% toluidine blue, and lysed with 1% SDS. Absorbance was measured at 590 nm.
Migration Assay
FCS (10%)-directed VSMC migration was examined in transwell cell culture chambers using gelatin-coated (0.2%) or vitronectincoated (10 g/mL) polycarbonate membranes with 8-m pores. Serum-starved VSMCs were transfected with asODNs or incubated with pharmacological inhibitor for 24 hours in serum-deprived DMEM and then used in experiments. The number of VSMCs per high-power field (magnification ϫ320) that migrated after 4 hours to the lower surface of the filters was determined microscopically. Four randomly chosen high-power fields were counted per filter.
Immunohistochemistry
Ten human carotid endarterectomy specimens (Stary stage 4 or above) were investigated. After primary antibody incubation overnight at 4°C, single labeling (PC5, 1:500; ␣-SMA, 1:50; ␣ v , 1:250; AB1930) was revealed with DAB using the ABC Histostain-Plus kit (Zymed). Double-immunocytochemical stainings of PC5 with ␣-SMA were done by combining alkaline phosphatase (Vector red) and horseradish peroxidase (DAB) as described. 19 Colocalization of polyclonal antibodies to PC5 and ␣ v was done using secondary biotinylated goat anti-rabbit and tertiary horseradish peroxidase Avdin-D antibodies (Vector) with Novared substrate (Vector) for ␣ v stainings first, followed by PC5 staining with secondary goat anti-rabbit alkaline phosphatase antibody using BCIP/NBT (Vector). Specificity controls were done by omission of the first antibody or incubation with nonimmune IgGs.
Statistical Analysis
ANOVA and paired or unpaired t test were performed for statistical analysis as appropriate. Statistical significance was designated at PϽ0.05. Values are expressed as meanϮSD.
Results
Proprotein Convertase Activity Is Required for ␣ v Activation in VSMCs
To investigate the contribution of PCs and MT1-MMP to ␣ v activation, pharmacological inhibitors were used. In controls, the antibody targeting the N-terminal sequence of ␣ v (VNR139) revealed a 150-kDa noncleaved ␣ v on nonreducing gels. However, under reducing conditions, when disulphidebound heavy chains (125 kDa) and light chains (25 kDa) are separated, a cleaved ␣ v 125-kDa heavy chain is detected ( Figure 1A) . The PC-inhibitor dec-CMK 22 (50 mol/L; 24 hours) significantly inhibited ␣ v cleavage, demonstrated by the presence of the noncleaved 150-kDa ␣ v on reducing gels ( Figure 1A) . In contrast, the MMP-inhibitor GM6001 (50 mol/L; 24 or 48 hours), recently reported to inhibit ␣ v cleavage, 20 had no effect ( Figure 1A) , even though mature MT1-MMP is present ( Figure 1B ). To assess that the concentration and incubation time of GM6001 was sufficient to inhibit MT1-MMP, conditioned medium was subject to zymography, demonstrating inhibition of pro-MMP-2 activation by GM6001, whereas dec-CMK had no effect ( Figure  1C ).
Because dec-CMK inhibits furin and PC5, specifically designed asODNs were used to silence PC5, the major integrin convertase. 17 Different PC5-asODNs were tested at different concentrations (0.5, 1, and 5 mol/L), revealing a concentration-dependent inhibition of FCS-induced PC5 levels by PC5-asODNs-1 and -2, whereas PC5-asODNs-3 was inactive (online Figure, panel A, available at http://www.circulationaha.org). PC5-asODNs-2 was the most potent sequence and was therefore used in additional experiments. A control asODNs targeting ␣ 1 -collagen 21 had no effect. Transfection efficiency was monitored by immunofluorescence, demonstrating nuclear uptake of asODNs with the help of transfection medium (online Figure, panel B) . At a concentration of 1 mol/L, PC5-asODNs reduced PC5 protein levels by approximately 60% (#PϽ0.05 versus controls, online Figure, panel C). Levels of furin were not affected by PC5-asODNs (online Figure, panel C) . Because of the incomplete transfection of primary cells (the percentage of VSMCs displaying nuclear uptake of PC5-asODNs-2 was approximately 60%), no complete inhibition of ␣ v cleavage could be achieved. Still, PC5-asODNs-2 significantly inhibited ␣ v activation, evident by the noncleaved 150-kDa ␣ v on reducing gels (Figure 2A ). Inhibition of ␣ v activation via inhibition of PC activity was additionally confirmed with an anti-␣ v integrin antibody (AB1930) recognizing the C-terminal fragment. PC5-asODNs-2 (1 mol/L; 24 hours) and dec-CMK (50 mol/L; 24 hours) caused a significant decrease of cleaved ␣ v light chain (25 kDa) on reducing SDS-PAGE (#PϽ0.05 versus controls), whereas GM6001 (50 mol/L; 24 hours) had no effect ( Figures 2B and 2C) . In contrast, GM6001 (GM; 50 mol/L; 24 hours), sense (se) and scrambled (scr) PC5-ODNs-2, the ␣ 1 -collagen asODNs (␣ 1 -as), and transfection medium (TM) had no effect. Reblotting of the membrane with ␣-SMA confirmed equal protein loading. Densitometry of B is depicted in C; #PϽ0.05 vs controls.
Proprotein Convertase PC5 Is Required for VSMC Adhesion and Migration on Vitronectin
Silencing PC5 with asODNs-2 (1 mol/L; 24 hours) or inhibition of PC activity with dec-CMK (50 mol/L; 24 hours) markedly inhibited VSMC adhesion to the ␣ v -ligand vitronectin (10 g/mL) ( Figure 3A , #PϽ0.05 versus controls). This inhibition was comparable to the ␣ v ␤ 5 blocking antibody P1F6 (25 g/mL; #PϽ0.05 versus nonspecific IgGs). In contrast, neither PC5-asODNs-2 nor dec-CMK significantly inhibited adhesion to type I collagen (20 g/mL) ( Figure 3B ). GM6001 (50 mol/L; 24 hour) did not inhibit adhesion on either of the matrices (Figures 3A and 3B ). PC5-asODNs-2 also inhibited VSMC migration on gelatincoated (0.2%) membranes in a concentration-dependent (0.5 and 1 mol/L) manner ( Figure 4A ; #PϽ0.05 versus controls). Similar results were obtained with vitronectin (10 g/mL) (#PϽ0.05 versus controls; Figure 4B ), which were comparable to P1F6 (25 g/mL; #PϽ0.05 versus nonspecific IgGs). In contrast, FCS-induced VSMC DNA synthesis was not affected by PC5-asODNs-2 (Table) .
Activation of ␣ v by Proprotein Convertases Is Required for Integrin-Dependent Signaling
To investigate the requirement of ␣ v cleavage by PCs for integrin-dependent signaling in VSMCs, cells were serum-starved with or without dec-CMK (50 mol/L) for 24 hours and then detached and allowed to adhere to vitronectin (10 g/mL) for 45 minutes. On adhesion to vitronectin, phosphorylation of FAK ( Figure 5A ), Akt ( Figure 5B ), and ERK1/2 ( Figure 5C ) was evident. Inhibition of ␣ v -cleavage with dec-CMK resulted in the inhibition of adhesion-induced FAK Y397 autophosphorylation and Akt phosphorylation (both #PϽ0.05 versus vitronectin alone), whereas ERK1/2 phosphorylation was not affected by the status of ␣ v cleavage. To demonstrate that the inhibition of integrin-dependent signaling was not attributable to a defect in the signaling cascades, serum-starved VSMCs, treated with or without dec-CMK, were stimulated with PDGF-BB (5 ng/mL) for 45 minutes. Growth factor stimulation resulted in a vigorous phosphorylation, indicating that signaling through these pathways is intact.
PC5 Expression in Human Carotid Plaques
Carotid atherosclerotic lesions (nϭ10) obtained by endarterectomy ( Figure 6A ) contained PC5 in the media underlying fibrous and lipid-rich lesions and in the edges of the lipid core Figure 3 . A, PC5-asODNs-2 (1 mol/L), dec-CMK (CMK; 50 mol/L), and the ␣ v ␤ 5 blocking antibody P1F6 (25 g/mL) significantly reduced VSMC adhesion to vitronectin (10 g/mL; #PϽ0.05 vs controls), whereas transfection medium (TM), sense (se) and scrambled (scr) PC5-ODNs-2, the ␣ 1 -collagen asODNs, and GM6001 (GM; 50 mol/L) had no effect. Nonspecific IgGs (50 g/mL) had no effect on VSMC adhesion to vitronectin (nϭ6). B, None of the inhibitors had a significant effect on VSMC adhesion to type I collagen (20 g/mL) (nϭ6). Figure 4 . A, PC5-asODNs-2 (0.5 and 1 mol/L) significantly reduced VSMC migration on gelatin-coated (0.2%) membranes in a concentration-dependent manner (#PϽ0.05 vs controls), whereas transfection medium (TM), sense (se), or scrambled (scr) ODNs had no effect (nϭ4). B, PC5-asODNs-2 and the ␣ v ␤ 5 blocking antibody P1F6 (25 g/mL) inhibited VSMC migration on vitronectin (10 g/mL) (both #PϽ0.05 vs controls). Nonspecific IgGs (50 g/mL), transfection medium (TM), and sense (se) or scrambled (scr) ODNs had no effect. Co indicates controls. nϭ4.
( Figure 6B ). Strong PC5 (brown, Figure 6C ) and ␣ v (brown, Figure 6E ) stainings were noted on serial sections in myofibroblasts ( Figure 6D , ␣-SMA) of the plaque cap ( Figure 6F , control). High magnification of PC5 staining in these cells is depicted in Figure 6G . PC5 colocalized with ␣-SMA ( Figure  6H , ␣-SMA alone; Figure 6J , double-labeling with PC5, brown). In these myofibroblasts, PC5 (blue) colocalizes with ␣ v (brown/red) ( Figure 6I ).
Discussion
Adhesive events, essential for cell migration, require dynamic interactions of the cell with the ECM, mediated by integrins. VSMC adhesion and migration requires ␣ v ␤ 3 /␤ 5 in vitro, 7, 8, 11 and blocking of ␣ v functions has been demonstrated to prevent neointima formation in vivo. 7, 8, 12 So far, there has been little focus on the characterization of enzymes responsible for the activation of the ␣ v subunit, which will potentially lead to novel strategies to limit VSMC-␣ v -integrinmatrix interactions in atherosclerosis and restenosis.
The present study demonstrates that PC5 is required for ␣ v activation in VSMCs, thereby controlling VSMC adhesion and migration as well as integrin-dependent signaling. According to our previous studies, ␣ v endoproteolysis occurs within the trans-Golgi-network of VSMCs, 19 where furin and PC5 are localized. 18 PC5, which is coordinately upregulated with ␣ v in VSMCs after balloon injury in rodents, 19 has been shown to be the major ␣ v convertase, being 3 times more potent than furin. 17 In our study, the pharmacological PC inhibitor dec-CMK 22 significantly inhibited cleavage of the 150-kDa ␣ v into the disulfide-bound 125-kDa heavy and 25-kDa light chains. Because dec-CMK inhibits furin and PC5, specific PC5-asODNs were used, revealing a significant inhibition of ␣ v activation in VSMCs. Furin, which shares several structural, biochemical, and cell biological features with PC5, 16 was not affected by PC5-asODNs.
More recently, an alternative pathway of ␣ v cleavage has been demonstrated based on the coexpression of ␣ v ␤ 3 and MT1-MMP in carcinoma cells. 20 In contrast to PCs, MT1-MMP generates a disulphide-bounded 115-kDa ␣ v heavy chain with a truncated C-terminus and a 25-kDa light chain, thereby facilitating carcinoma cell adhesion and migration on vitronectin. 23 We found that silencing PC5 levels by specific asODNs inhibited VSMC migration on vitronectin. In contrast, we did not find inhibition of ␣ v cleavage or inhibition of adhesion to vitronectin on MT1-MMP inhibition using GM6001 as reported, 20 making it unlikely that MT1-MMP significantly contributes to ␣ v activation in VSMCs. MT1-MMP, which activates MMP-2, 24 may undergo endoproteolytic activation by furin-like convertases itself. 25 Interest- VSMCs were serum-starved for 48 hours and than transfected with ODNs followed by stimulation with 5% FCS. BrdU was added after 24 hours of stimulation for another 8 hours, and supernatants where then analyzed with a commercially available ELISA (Boehringer). *PϽ0.05 vs serum-starved controls. Values are meanϮSD; nϭ3.
FCS-Induced VSMC DNA Synthesis After Transfection With ODNs
Figure 5.
To investigate the effect of PC inhibition and, consequently, inhibition of ␣ v cleavage for integrin-dependent signaling, VSMCs were serum-starved with or without dec-CMK (CMK; 50 mol/L) for 24 hours and then detached and allowed to adhere to vitronectin (10 g/mL) for 45 minutes. Inhibition of ␣ v cleavage inhibited adhesion-induced FAK Y397 -autophosphorylation (A) and Akt-phosphorylation (B) (both #PϽ0.05 vs controls), whereas ERK1/2-phosphorylation was not affected (C). Total FAK, Akt, or ERK1/2 levels did not change. PDGF-BB (5 ng/mL)-induced phosphorylation of these signaling proteins was not affected in dec-CMK-treated VSMCs.
ingly, dec-CMK (or PC5-asODNs-2; data not shown) did not inhibit the activation of pro-MMP-2 in VSMCs, as noticed by others previously. 26 This suggests that furin/PC5 might not contribute to MT1-MMP activation in VSMCs, which can function as a self-convertase. 27 In our study, silencing PC5 levels with specific asODNs or inhibiting PC-activity with dec-CMK and thus consequently inhibiting ␣ v activation inhibited VSMC adhesion and migration on vitronectin. It did not affect VSMC adhesion to type I collagen. Our data are in accordance with Berthet el al, 15 who demonstrated inhibition of ␣ v cleavage in adenocarci-noma cells transfected with the PC inhibitor ␣ 1 -PDX (␣ 1 -Antitrypsin Portland). Adhesion of ␣ 1 -PDX transfectants to vitronectin, but not to type I collagen, was significantly inhibited, 15 presumably because the ␣ 2 -subunit, which recognizes type I collagen via a DGEA sequence, is not endoproteolytically cleaved. 5 Vitronectin, which is recognized by ␣ v -containing integrins and the platelet ␣ IIb ␤ 3 , 5 regulates VSMC migration via interaction with ␣ v ␤ 3 /␤ 5 . 7, 8 Both ␣ v integrins and vitronectin are upregulated in human atherosclerotic plaques. 9,10 Likewise, we found PC5 in human carotid plaques. PC5 colocalized with ␣ v in VSMCs in the atherosclerotic lesions, supporting a role for PC5 in the atherosclerotic process.
There is growing evidence that cleavage of ␣-subunits may not represent solely precursor maturation but can affect and regulate integrin signaling. 14, 15, 23 Uncleaved ␣-subunits might have signaling competence, because they are expressed on the cell surface, maintain their RGD-binding properties, 14, 15 and coimmunoprecipitate with the integrin-signaling adapter molecules Shr/Gbr2. 28 A central role in mediating integrin signaling is played by the autophosphorylation of FAK at tyrosine 397 on ECM adhesion, which promotes cell motility. 29 It has been shown that adhesion-dependent FAK phosphorylation requires ␣ v cleavage by PCs. 15 Whereas autophosphorylated FAK Y397 binds PI3-kinase and increases its activity, 30 integrin-dependent ERK1/2 activation may occur independently of FAK. 31 Activation of PI3-kinase by FAK Y397 facilitates cell migration. 32 In this study we demonstrate that inhibition of ␣ v cleavage by PCs represses integrin-dependent FAK Y397 autophosphorylation and subsequent phosphorylation of Akt, the major PI3-kinase target. In contrast, ERK1/2 phosphorylation was not affected by inhibition of ␣ v cleavage, indicating that the status of ␣ v cleavage could diversely regulate signaling pathways on cell adhesion.
In conclusion, the present study demonstrates that PC5mediated ␣ v endoproteolytic activation is necessary for ␣ vdependent VSMC adhesion and migration as well as signaling. Inhibiting PC5 might thus be a novel target to modulate ␣ v -dependent signaling and VSMC functions during the development and progression of atherosclerosis or restenosis. Figure 6 . Carotid atherosclerotic lesions obtained by endarterectomy (A, hematoxylin phloxine saffron staining) contained PC5 (brown) in the media underlying fibrous and lipid-rich lesions and in the edges of the lipid core (B). Strong PC5 and ␣ v were found in spindle-shaped myofibroblasts of the plaque cap, evident by staining of serial section (C, PC5, brown; D, ␣-SMA, red; E, ␣ v , brown; F, control). Higher magnification of PC5 staining (brown) in these myofibroblasts is depicted in G. PC5 colocalized with ␣-SMA (H, ␣-SMA staining alone, red; J, doublelabeling with PC5, brown). In these myofibroblasts, PC5 (blue) colocalizes with ␣ v (brown/red) (I). Nuclei are stained with hematoxylin in B, C, E through G, and J. Size bar in F for C through E and in J for G through I.
